inHeart enrolls European patients for AI heart model trial

By staff writers

May 2, 2022 -- Medical device company inHeart has began enrollment in Europe for a randomized control trial for the company's artificial intelligence (AI)-enabled digital twin of the heart.

The inEurHeart clinical study is a multicenter, prospective, blind randomized controlled trial that aims to compare the efficiency and efficacy of image-guided ventricular tachycardia ablations to conventional, catheter-based methods. The company said it wants to enroll 112 patients in 15 heart centers across four European countries over the next 12 months.

The inHeart software uses a proprietary segmentation algorithm that analyzes CT or MR images to create interactive 3D heart models. The company said this could help physicians develop treatment strategies for individual patients.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking